Angiopoietin-2 in ischemic cardiac patients

Background: Coronary artery disease (CAD) is the most common cause of death globally according to WHO. Its known that ischemia and cardiac dysfunction promotes the angiogenesis and new vessel formation to compensate for the decreased blood supply through the diseased arteries.Angiopoietin-2(Ang-2) a...

Full description

Bibliographic Details
Main Authors: Ahmed Magdy Abdelazim*, Mohammed Abdelrazek Elsenbsy, Mohammed H. Hassan, Mohammed AK
Format: Article
Language:English
Published: South Valley University, Faculty of Medicine 2023-07-01
Series:SVU - International Journal of Medical Sciences
Subjects:
Online Access:https://svuijm.journals.ekb.eg/article_155114.html
_version_ 1827894467005251584
author Ahmed Magdy Abdelazim*
Mohammed Abdelrazek Elsenbsy
Mohammed H. Hassan
Mohammed AK
author_facet Ahmed Magdy Abdelazim*
Mohammed Abdelrazek Elsenbsy
Mohammed H. Hassan
Mohammed AK
author_sort Ahmed Magdy Abdelazim*
collection DOAJ
description Background: Coronary artery disease (CAD) is the most common cause of death globally according to WHO. Its known that ischemia and cardiac dysfunction promotes the angiogenesis and new vessel formation to compensate for the decreased blood supply through the diseased arteries.Angiopoietin-2(Ang-2) along with several other growth factors are responsible for the process of new vessel formation. Many patients have some degree of renal insufficiency post PCI mainly due to contrast media and are associated with rise in the serum Ang-2 level. Ang-2 is found to be decreased post PCI with the restoration of the normal blood flow. Many clinical trials relate the Ang-2 with the severity of CAD and renal function. Objectives: Highlight the serum levels of Ang-2 pre and post PCI and its validity to be used to diagnose and predict severity of CAD. Methods: We have searched literatures in PubMed, google scholar, Egyptian bank of knowledge and science direct. Conclusion: In this review we emphasize that Ang-2 is found to be an important marker for diagnosis and prognosis of CAD and is closely related to renal functions in ischemic cardiac patients candidate for PCI.
first_indexed 2024-03-12T22:07:57Z
format Article
id doaj.art-55be35318981407e8a4d041a7c77f3a0
institution Directory Open Access Journal
issn 2735-427X
2636-3402
language English
last_indexed 2024-03-12T22:07:57Z
publishDate 2023-07-01
publisher South Valley University, Faculty of Medicine
record_format Article
series SVU - International Journal of Medical Sciences
spelling doaj.art-55be35318981407e8a4d041a7c77f3a02023-07-24T09:33:13ZengSouth Valley University, Faculty of MedicineSVU - International Journal of Medical Sciences2735-427X2636-34022023-07-0162 482488https://doi.org/10.21608/svuijm.2021.66008.1111Angiopoietin-2 in ischemic cardiac patientsAhmed Magdy Abdelazim*0Mohammed Abdelrazek Elsenbsy 1Mohammed H. Hassan 2Mohammed AK3Department of Internal Medicine, Faculty of Medicine, South Valley University, Qena, 83523 Egypt.Department of Internal Medicine, Faculty of Medicine, South Valley University, Qena, 83523 Egypt.; Internal Medicine Department ,Arabian Gulf University(AGU),Bahrain.Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, South Valley University, Qena, EgyptCardiology Division of Internal Medicine Department, South Valley University Hospital, Faculty of Medicine, South Valley University, Qena, 83523 Egypt.Background: Coronary artery disease (CAD) is the most common cause of death globally according to WHO. Its known that ischemia and cardiac dysfunction promotes the angiogenesis and new vessel formation to compensate for the decreased blood supply through the diseased arteries.Angiopoietin-2(Ang-2) along with several other growth factors are responsible for the process of new vessel formation. Many patients have some degree of renal insufficiency post PCI mainly due to contrast media and are associated with rise in the serum Ang-2 level. Ang-2 is found to be decreased post PCI with the restoration of the normal blood flow. Many clinical trials relate the Ang-2 with the severity of CAD and renal function. Objectives: Highlight the serum levels of Ang-2 pre and post PCI and its validity to be used to diagnose and predict severity of CAD. Methods: We have searched literatures in PubMed, google scholar, Egyptian bank of knowledge and science direct. Conclusion: In this review we emphasize that Ang-2 is found to be an important marker for diagnosis and prognosis of CAD and is closely related to renal functions in ischemic cardiac patients candidate for PCI.https://svuijm.journals.ekb.eg/article_155114.htmlpercutaneous coronary intervention (pci)contrast induced nephropathy (cin)angiopoietin-2(ang-2)
spellingShingle Ahmed Magdy Abdelazim*
Mohammed Abdelrazek Elsenbsy
Mohammed H. Hassan
Mohammed AK
Angiopoietin-2 in ischemic cardiac patients
SVU - International Journal of Medical Sciences
percutaneous coronary intervention (pci)
contrast induced nephropathy (cin)
angiopoietin-2(ang-2)
title Angiopoietin-2 in ischemic cardiac patients
title_full Angiopoietin-2 in ischemic cardiac patients
title_fullStr Angiopoietin-2 in ischemic cardiac patients
title_full_unstemmed Angiopoietin-2 in ischemic cardiac patients
title_short Angiopoietin-2 in ischemic cardiac patients
title_sort angiopoietin 2 in ischemic cardiac patients
topic percutaneous coronary intervention (pci)
contrast induced nephropathy (cin)
angiopoietin-2(ang-2)
url https://svuijm.journals.ekb.eg/article_155114.html
work_keys_str_mv AT ahmedmagdyabdelazim angiopoietin2inischemiccardiacpatients
AT mohammedabdelrazekelsenbsy angiopoietin2inischemiccardiacpatients
AT mohammedhhassan angiopoietin2inischemiccardiacpatients
AT mohammedak angiopoietin2inischemiccardiacpatients